6-[N-(2-chloropyrimidin-4-yl)amino]-2,3-dimethyl-2H-indazole
![BK37HG | 444731-74-2 | 6-[N-(2-chloropyrimidin-4-yl)amino]-2,3-dimethyl-2H-indazole](https://qncdn.chemcd.cn/alchemypharm/444731-74-2.png "BK37HG | 444731-74-2 | 6-[N-(2-chloropyrimidin-4-yl)amino]-2,3-dimethyl-2H-indazole")
Catalog No.: BK37HG
CAS.RN：444731-74-2
Molecular Formula: C13H12ClN5
Molecular Weight: 273.72 g/mol
Purity: NLT 98%
Intermediates of Pazopanib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA72CU | Pazopanib API | 444731-52-6 |
| BK2H00 | 3-Methyl-6-nitro-1H-Indazole | 6494-19-5 |
| BK33D5 | 2,3-dimethyl-6-nitro-2H-indazole | 444731-73-1 |
| BK8X9U | 3-Amino-6-methylbenzenesulfonam | 6973-09-7 |
| BK385H | 2,3-dimethyl-6-amino-2H-carbazole dihydrochloride | |
| BK8D25 | 2,4-Dichlorpyrimidin | 3934-20-1 |
| BK2T60 | Pazopanib Hydrochloride | 635702-64-6 |
| BK23Q8 | 2,3-Dimethyl-2H-indazol-6-amine | 444731-72-0 |
| BK73M8 | 2,3-Dimethyl-2H-indazol-6-amine hydrochloride | 635702-60-2 |
| BK37HG | 6-[N-(2-chloropyrimidin-4-yl)amino]-2,3-dimethyl-2H-indazole | 444731-74-2 |
| BK752F | N-(2-Chloropyrimidin-4-yl)-N-methyl-2,3-dimethyl-2H-indazol-6-amine | 444731-75-3 |
| BK9K7N | 2,3-Dimethyl-6-amino-2H-indazole (dihydrochloride) | 2446590-67-4 |
| BK16TB | 6-Nitroindazole | 7597-18-4 |
| BK8LV9 | 2-Cyano-phenothiazine | 38642-74-9 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
